275 related articles for article (PubMed ID: 18606224)
1. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
[TBL] [Abstract][Full Text] [Related]
2. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
Muatlik S; Usha AN; Reddy MS; Ranjith AK; Pandey S
Pak J Pharm Sci; 2007 Jul; 20(3):218-26. PubMed ID: 17545107
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
Mutalik S; Anju P; Manoj K; Usha AN
Int J Pharm; 2008 Feb; 350(1-2):279-90. PubMed ID: 17945447
[TBL] [Abstract][Full Text] [Related]
4. Preparation, evaluation and need of spherical crystallization in case of high speed direct tabletting.
Pandey S; Patil AT
Curr Drug Deliv; 2014; 11(2):179-90. PubMed ID: 23848355
[TBL] [Abstract][Full Text] [Related]
5. Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac.
Mutalik S; Naha A; Usha AN; Ranjith AK; Musmade P; Manoj K; Anju P; Prasanna S
Arch Pharm Res; 2007 Feb; 30(2):222-34. PubMed ID: 17366745
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
Maghsoodi M; Tajalli Bakhsh AS
Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
[TBL] [Abstract][Full Text] [Related]
7. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
[TBL] [Abstract][Full Text] [Related]
8. Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.
Mutalik S; Manoj K; Reddy MS; Kushtagi P; Usha AN; Anju P; Ranjith AK; Udupa N
AAPS PharmSciTech; 2008; 9(2):651-9. PubMed ID: 18500561
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of deformable talc agglomerates prepared by crystallo-co-agglomeration technique for generating heterogeneous matrix.
Jadhav N; Pawar A; Paradkar A
AAPS PharmSciTech; 2007 Jul; 8(3):E59. PubMed ID: 17915809
[TBL] [Abstract][Full Text] [Related]
10. Effect of processing variables on micro particulate system of aceclofenac.
Dashora K; Saraf S; Saraf S
Pak J Pharm Sci; 2006 Jan; 19(1):6-10. PubMed ID: 16632445
[TBL] [Abstract][Full Text] [Related]
11. Trials of clear aceclofenac-loaded soft capsules with accelerated oral absorption in human subjects.
Yong CS; Oh YK; Lee KH; Park SM; Park YJ; Gil YS; Yu CH; Yoo BK; Woo JS; Kim JO; Rhee JD; Kim CK; Choi HG
Int J Pharm; 2005 Sep; 302(1-2):78-83. PubMed ID: 16107306
[TBL] [Abstract][Full Text] [Related]
12. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
13. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
14. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
[TBL] [Abstract][Full Text] [Related]
15. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
[TBL] [Abstract][Full Text] [Related]
16. Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique.
Maghsoodi M
Pharm Dev Technol; 2011 Oct; 16(5):474-82. PubMed ID: 20557281
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis.
Qureshi J; Ahuja A; Baboota S; Chutani K; Jain S; Ali J
Methods Find Exp Clin Pharmacol; 2009; 31(1):15-23. PubMed ID: 19357794
[TBL] [Abstract][Full Text] [Related]
18. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
Mourão SC; da Silva C; Bresolin TM; Serra CH; Porta V
Int J Pharm; 2010 Feb; 386(1-2):201-7. PubMed ID: 19941944
[TBL] [Abstract][Full Text] [Related]
19. Crystallo-co-agglomeration: a novel technique to obtain ibuprofen-paracetamol agglomerates.
Pawar AP; Paradkar AR; Kadam SS; Mahadik KR
AAPS PharmSciTech; 2004 Jun; 5(3):e44. PubMed ID: 15760077
[TBL] [Abstract][Full Text] [Related]
20. Improved compressibility, flowability, dissolution and bioavailability of pioglitazone hydrochloride by emulsion solvent diffusion with additives.
Patil SV; Pawar AP; Sahoo SK
Pharmazie; 2012 Mar; 67(3):215-23. PubMed ID: 22530302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
